Altimmune
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-2.85-2.02-2.561.21
Price/Sales ratio
5.7246.902.590.23
Earnings per Share (EPS)
$-1.26$-1.77$-1.40$2.97

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-2.56-8.250.15-0.54-0.14-1.20-5.89-3.93-9.11-6.77-2.29-1.20
Price/Sales ratio
2.502.665.86613.970.554.2735.3385.74-11.35K1.40K-2.85K4.27
Price/Book Value ratio
1.391.701.570.520.110.541.281.894.163.081.040.11
Price/Cash Flow ratio
-3.01-8.830.15-1.26-0.61-2.58-8.39-4.83-12.33-7.90-3.10-2.58
Price/Free Cash Flow ratio
-2.98-8.600.15-1.25-0.55-2.57-8.31-4.17-12.30-7.89-3.09-2.57
Price/Earnings Growth ratio
0.100.110.00-0.000.000.01-0.26-0.170.400.81-0.090.01
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
58.14%52.41%-38.07%-44249.39%-78.67%-194.16%-309.39%87.49%200%-11.97%N/A-78.67%
Operating Profit Margin
-100.01%-31.97%-215.37%-125401.19%-414.61%-369.99%-669.49%-2197.41%129029.41%-22518.54%129029.41%-414.61%
Pretax Profit Margin
-97.08%-31.75%3919.99%-125445.78%-438.68%-354.71%-665.37%-2201.42%124867.64%-20762.20%124867.64%-438.68%
Net Profit Margin
-97.69%-32.33%3706.44%-111860.32%-379.15%-353.70%-599.19%-2180.57%124577.94%-20762.20%124577.94%-379.15%
Effective Tax Rate
-0.62%-1.82%5.44%10.82%13.56%0.28%9.94%0.94%0.23%N/A0.23%0.28%
Return on Assets
-45.29%-17.32%86.25%-73.65%-71.54%-37.95%-20.00%-43.94%-40.93%-41.98%-40.93%-71.54%
Return On Equity
-54.47%-20.66%996.21%-95.37%-81.07%-45.07%-21.71%-48.29%-45.71%-45.56%-44.02%-81.07%
Return on Capital Employed
-52.54%-19.24%-56.59%-87.92%-85.28%-42.81%-23.50%-48.31%-46.20%-48.32%-46.20%-85.28%
Liquidity Ratios
Current Ratio
7.457.901.086.118.6910.0419.15N/AN/AN/A11.308.69
Quick Ratio
7.457.901.085.198.69138.48182.11743.7411.3017.2610.988.69
Cash ratio
7.227.140.752.287.442.289.6410.416.5111.126.512.28
Days of Sales Outstanding
14.6150.6069.7289.42K157.95103.82551.7535.50-13.63K4.15K-13.63K103.82
Days of Inventory outstanding
N/AN/AN/A70.08N/A-10.77K-21.33K-8.86M182.5N/AN/AN/A
Operating Cycle
14.6150.6069.7289.49K157.95-10.67K-20.78K-8.86M-13.45K4.15KN/AN/A
Days of Payables Outstanding
33.4937.56101.352.557.370.386.661.34K25.78K1.58KN/A0.38
Cash Conversion Cycle
-18.8713.04-31.6289.48K150.58-10.67K-20.79K-8.86M-39.24K2.57KN/AN/A
Debt Ratios
Debt Ratio
0.03N/A0.000.010.01N/AN/AN/AN/AN/A0.100.01
Debt Equity Ratio
0.04N/A0.050.010.01N/AN/AN/AN/AN/A0.110.01
Long-term Debt to Capitalization
N/AN/A0.020.010.01N/AN/AN/AN/AN/A0.00N/A
Total Debt to Capitalization
0.03N/A0.040.010.01N/AN/AN/AN/AN/A0.00N/A
Interest Coverage Ratio
N/AN/AN/A-99.45-60.22-9.11K-5.81KN/AN/AN/A-10.96K-9.11K
Cash Flow to Debt Ratio
-11.35N/A204.66-31.11-16.39N/AN/AN/AN/AN/A-55.68N/A
Company Equity Multiplier
1.201.1911.541.291.131.181.081.091.111.081.111.18
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-0.83-0.3038.52-487.05-0.90-1.65-4.20-17.73920.38-177.95920.38-0.90
Free Cash Flow / Operating Cash Flow Ratio
1.011.020.991.001.101.001.001.151.001.001.001.00
Cash Flow Coverage Ratio
-11.35N/A204.66-31.11-16.39N/AN/AN/AN/AN/A-55.68N/A
Short Term Coverage Ratio
-11.35N/A439.37-406.70-131.13N/AN/AN/AN/AN/A-138.46N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A